Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Maryland › Germantown
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Germantown, MD keessatti
Qorannoo 17 Kansara Qara'a Non-Small Cell f Germantown fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Virgnia Cancer Specialists /ID# 269633, Leesburg · Miili 16 fagaatti
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · Miili 4 fagaatti
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology (MOH) ( Site 8102), Rockville · Miili 9 fagaatti
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology P.A., Germantown
- Maryland Oncology Hematology PA, Rockville · Miili 9 fagaatti
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Frederick · Miili 18 fagaatti
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology, P.A., Germantown
- Maryland Oncology Hematology, P.A., Rockville · Miili 9 fagaatti
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- James M Stockman Cancer Institute, Frederick · Miili 18 fagaatti
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Leesburg · Miili 16 fagaatti
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick · Miili 18 fagaatti
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- Local Institution - 007-814-C, Leesburg · Miili 16 fagaatti
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Namoota walitti qabaa jiraSadarkaa 3
- Inova Loudoun Hospital, Leesburg · Miili 16 fagaatti
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Namoota walitti qabaa jiraSadarkaa 1/2
- USOR Maryland Oncology Hematology, Rockville · Miili 9 fagaatti
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Frederick Health Hospital, Frederick · Miili 18 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · Miili 4 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · Miili 4 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · Miili 4 fagaatti
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Frederick Health Regional System, Frederick · Miili 18 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Germantown keessatti
- SchizophreniaQorannoo 11
- Saree OljooQorannoo 10
- Dhibee QaraQorannoo 9
- Saree (Gosoota Hunda)Qorannoo 7
- DepreshiniiQorannoo 7
- ObesityQorannoo 7
- Sukkaraa Gosa 2Qorannoo 7
- Dhibee Onneessaa fi DhiigaQorannoo 6
- Dukkana BladderQorannoo 6
- Baayyee UlfaataaQorannoo 5
- Dhibee Gaddii GuddaaQorannoo 5
- Dhiibbaa Dhiigaa Ol'aanaaQorannoo 4
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.